New on the Web
Notice of Funding Opportunity (NOFO) PS18-1802: Integrated HIV surveillance and prevention programs for health departments: Component A funding tableThis table includes annual funding amounts per state for PS18-1802 award recipients.
2018 Quick reference guide: Recommended laboratory HIV testing algorithm for serum or plasma specimensThis guide updates the 2014 laboratory HIV testing algorithm guidance, as a key HIV supplemental test was withdrawn from the market and replaced with a newer, rapid HIV supplemental test that is automatically read, and has multiple interpretations for users.
MMWR: Status of HIV epidemic control among adolescent girls and young women aged 15–24 Years — Seven African countries, 2015–2017In 2016, an estimated 1.5 million adolescent girls and young women were living with HIV infection in Eastern and Southern Africa, where HIV prevalence among adolescent girls and young women is more than twice that of their male peers. The authors concluded that there is a need to design, implement, and evaluate strategies aimed at ensuring HIV-positive adolescent girls and young women know their HIV status and are on ART treatment to improve their immunity status and reduce transmission to others.
MMWR: HIV infection and HIV-associated behaviors among persons who inject drugs — 20 Cities, United States, 2015
In 2015, National HIV Behavioral Surveillance found a 7% prevalence of HIV infection among persons who inject drugs which was lower than in 2012 (11%). Among HIV-negative respondents, 27% reported sharing syringes and 67% reported having vaginal sex without a condom in the previous 12 months; only 52% received syringes from a syringe services program and 34% received all syringes from sterile sources. HIV infection prevalence was higher among blacks (11%) than whites (6%) but more white persons who inject drugs shared syringes (white: 39%; black: 17%) and injection equipment (white: 61%; black: 41%) in the previous 12 months.